
OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Identification and validation of lncRNAs involved in m6A regulation for patients with ovarian cancer
Jianfeng Zheng, Jialu Guo, Benben Cao, et al.
Cancer Cell International (2021) Vol. 21, Iss. 1
Open Access | Times Cited: 42
Jianfeng Zheng, Jialu Guo, Benben Cao, et al.
Cancer Cell International (2021) Vol. 21, Iss. 1
Open Access | Times Cited: 42
Showing 1-25 of 42 citing articles:
LncRNA CACNA1G-AS1 up-regulates FTH1 to inhibit ferroptosis and promote malignant phenotypes in ovarian cancer cells
Yanping Jin, Jianping Qiu, Xiufang Lu, et al.
Oncology Research Featuring Preclinical and Clinical Cancer Therapeutics (2023) Vol. 31, Iss. 2, pp. 169-179
Open Access | Times Cited: 25
Yanping Jin, Jianping Qiu, Xiufang Lu, et al.
Oncology Research Featuring Preclinical and Clinical Cancer Therapeutics (2023) Vol. 31, Iss. 2, pp. 169-179
Open Access | Times Cited: 25
Construction of Ovarian Cancer Prognostic Model Based on the Investigation of Ferroptosis-Related lncRNA
Shaoyi Yang, Jie Ji, Meng Wang, et al.
Biomolecules (2023) Vol. 13, Iss. 2, pp. 306-306
Open Access | Times Cited: 16
Shaoyi Yang, Jie Ji, Meng Wang, et al.
Biomolecules (2023) Vol. 13, Iss. 2, pp. 306-306
Open Access | Times Cited: 16
Emerging role of m6A modification in ovarian cancer: progression, drug resistance, and therapeutic prospects
Shahil Alam, P. Giri
Frontiers in Oncology (2024) Vol. 14
Open Access | Times Cited: 5
Shahil Alam, P. Giri
Frontiers in Oncology (2024) Vol. 14
Open Access | Times Cited: 5
A methylation- and immune-related lncRNA signature to predict ovarian cancer outcome and uncover mechanisms of chemoresistance
Lu Chen, Wujiang Gao, Lin Li, et al.
Journal of Ovarian Research (2023) Vol. 16, Iss. 1
Open Access | Times Cited: 13
Lu Chen, Wujiang Gao, Lin Li, et al.
Journal of Ovarian Research (2023) Vol. 16, Iss. 1
Open Access | Times Cited: 13
Novel insights into the multifaceted roles of m6A-modified LncRNAs in cancers: biological functions and therapeutic applications
Jinxin Tang, Jinhui Zhang, Lu Yu, et al.
Biomarker Research (2023) Vol. 11, Iss. 1
Open Access | Times Cited: 11
Jinxin Tang, Jinhui Zhang, Lu Yu, et al.
Biomarker Research (2023) Vol. 11, Iss. 1
Open Access | Times Cited: 11
Development and verification of a 7-lncRNA prognostic model based on tumor immunity for patients with ovarian cancer
Jing Feng, Yiping Yu, Wen Yin, et al.
Journal of Ovarian Research (2023) Vol. 16, Iss. 1
Open Access | Times Cited: 9
Jing Feng, Yiping Yu, Wen Yin, et al.
Journal of Ovarian Research (2023) Vol. 16, Iss. 1
Open Access | Times Cited: 9
Glycosylation-Related Genes Predict the Prognosis and Immune Fraction of Ovarian Cancer Patients Based on Weighted Gene Coexpression Network Analysis (WGCNA) and Machine Learning
Chen Zhao, Kewei Xiong, Fangrui Zhao, et al.
Oxidative Medicine and Cellular Longevity (2022) Vol. 2022, pp. 1-23
Open Access | Times Cited: 14
Chen Zhao, Kewei Xiong, Fangrui Zhao, et al.
Oxidative Medicine and Cellular Longevity (2022) Vol. 2022, pp. 1-23
Open Access | Times Cited: 14
The m6A-Related Long Noncoding RNA Signature Predicts Prognosis and Indicates Tumor Immune Infiltration in Ovarian Cancer
Rui Geng, Tian Chen, Zihang Zhong, et al.
Cancers (2022) Vol. 14, Iss. 16, pp. 4056-4056
Open Access | Times Cited: 14
Rui Geng, Tian Chen, Zihang Zhong, et al.
Cancers (2022) Vol. 14, Iss. 16, pp. 4056-4056
Open Access | Times Cited: 14
Constructing and validating of m6a-related genes prognostic signature for stomach adenocarcinoma and immune infiltration: Potential biomarkers for predicting the overall survival
Jing Yang, Zixuan Wu, Xiaoxi Wu, et al.
Frontiers in Oncology (2022) Vol. 12
Open Access | Times Cited: 14
Jing Yang, Zixuan Wu, Xiaoxi Wu, et al.
Frontiers in Oncology (2022) Vol. 12
Open Access | Times Cited: 14
A Prognostic Signature for Colon Adenocarcinoma Patients Based on m6A-Related lncRNAs
Suzhe Zhou, Yinglian Pan, Qingchun Deng, et al.
Journal of Oncology (2023) Vol. 2023, pp. 1-13
Open Access | Times Cited: 8
Suzhe Zhou, Yinglian Pan, Qingchun Deng, et al.
Journal of Oncology (2023) Vol. 2023, pp. 1-13
Open Access | Times Cited: 8
Fatty Acid Metabolism-Related lncRNA Prognostic Signature for Serous Ovarian Carcinoma
Lele Ye, Zhuofeng Jiang, Mengxia Zheng, et al.
Epigenomics (2024) Vol. 16, Iss. 5, pp. 309-329
Closed Access | Times Cited: 2
Lele Ye, Zhuofeng Jiang, Mengxia Zheng, et al.
Epigenomics (2024) Vol. 16, Iss. 5, pp. 309-329
Closed Access | Times Cited: 2
Novel protein-based prognostic signature linked to immunotherapeutic efficiency in ovarian cancer
Shuo‐Fu Chen, Liang-Yun Wang, Yi-Sian Lin, et al.
Journal of Ovarian Research (2024) Vol. 17, Iss. 1
Open Access | Times Cited: 2
Shuo‐Fu Chen, Liang-Yun Wang, Yi-Sian Lin, et al.
Journal of Ovarian Research (2024) Vol. 17, Iss. 1
Open Access | Times Cited: 2
Identification and validation of a seven m6A-related lncRNAs signature predicting prognosis of ovarian cancer
Yang Song, Hui Qu
BMC Cancer (2022) Vol. 22, Iss. 1
Open Access | Times Cited: 12
Yang Song, Hui Qu
BMC Cancer (2022) Vol. 22, Iss. 1
Open Access | Times Cited: 12
RETRACTED ARTICLE: Long noncoding RNA UBA6-AS1 inhibits the malignancy of ovarian cancer cells via suppressing the decay of UBA6 mRNA
Yaogang Wang, Zhigao Chen
Bioengineered (2021) Vol. 13, Iss. 1, pp. 178-189
Open Access | Times Cited: 17
Yaogang Wang, Zhigao Chen
Bioengineered (2021) Vol. 13, Iss. 1, pp. 178-189
Open Access | Times Cited: 17
Four Types of RNA Modification Writer-Related lncRNAs Are Effective Predictors of Prognosis and Immunotherapy Response in Serous Ovarian Carcinoma
Lele Ye, Kan Pan, Su Fang, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 10
Lele Ye, Kan Pan, Su Fang, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 10
Study of Neuronal Apoptosis ceRNA Network in Hippocampal Sclerosis of Human Temporal Lobe Epilepsy by RNA-Seq
Shengkun Yu, Yifei Gu, Tianyu Wang, et al.
Frontiers in Neuroscience (2021) Vol. 15
Open Access | Times Cited: 13
Shengkun Yu, Yifei Gu, Tianyu Wang, et al.
Frontiers in Neuroscience (2021) Vol. 15
Open Access | Times Cited: 13
The Long Non-Coding RNA SNHG12 as a Mediator of Carboplatin Resistance in Ovarian Cancer via Epigenetic Mechanisms
Cecilie Abildgaard, Luísa Matos do Canto, Cláudia Aparecida Rainho, et al.
Cancers (2022) Vol. 14, Iss. 7, pp. 1664-1664
Open Access | Times Cited: 9
Cecilie Abildgaard, Luísa Matos do Canto, Cláudia Aparecida Rainho, et al.
Cancers (2022) Vol. 14, Iss. 7, pp. 1664-1664
Open Access | Times Cited: 9
Analysis and prognostic significance of tumour immune infiltrates and immune microenvironment of m6A-related lncRNAs in patients with gastric cancer
Jia-Rong Huang, Jinxuan Song, xiangyu Li, et al.
BMC Medical Genomics (2022) Vol. 15, Iss. 1
Open Access | Times Cited: 8
Jia-Rong Huang, Jinxuan Song, xiangyu Li, et al.
BMC Medical Genomics (2022) Vol. 15, Iss. 1
Open Access | Times Cited: 8
m6A-Related lncRNA Signature Is Involved in Immunosuppression and Predicts the Patient Prognosis of the Age-Associated Ovarian Cancer
Ming Li, Liang Zhang, Miaoxiao Feng, et al.
Journal of Immunology Research (2022) Vol. 2022, pp. 1-16
Open Access | Times Cited: 6
Ming Li, Liang Zhang, Miaoxiao Feng, et al.
Journal of Immunology Research (2022) Vol. 2022, pp. 1-16
Open Access | Times Cited: 6
Development of a novel angiogenesis-related lncRNA signature to predict the prognosis and immunotherapy of glioblastoma multiforme
Binbin Zhang, Yaling Cheng, Ruichun Li, et al.
Translational Cancer Research (2022) Vol. 12, Iss. 1, pp. 13-30
Open Access | Times Cited: 6
Binbin Zhang, Yaling Cheng, Ruichun Li, et al.
Translational Cancer Research (2022) Vol. 12, Iss. 1, pp. 13-30
Open Access | Times Cited: 6
m6A‐related lncRNAs as potential biomarkers and the lncRNA ELFN1‐AS1/miR‐182‐5p/BCL‐2 regulatory axis in diffuse large B‐cell lymphoma
Qinglong Yang, Yingxue Lu, Ashuai Du
Journal of Cellular and Molecular Medicine (2023) Vol. 28, Iss. 2
Open Access | Times Cited: 3
Qinglong Yang, Yingxue Lu, Ashuai Du
Journal of Cellular and Molecular Medicine (2023) Vol. 28, Iss. 2
Open Access | Times Cited: 3
Construction of a Macrophage Infiltration Regulatory Network and Related Prognostic Model of High-Grade Serous Ovarian Cancer
Hua Chang, Yuyan Zhu, Jiahui Zheng, et al.
Journal of Oncology (2021) Vol. 2021, pp. 1-17
Open Access | Times Cited: 8
Hua Chang, Yuyan Zhu, Jiahui Zheng, et al.
Journal of Oncology (2021) Vol. 2021, pp. 1-17
Open Access | Times Cited: 8
Potential Prognostic Value of a Seven m6A-Related LncRNAs Signature and the Correlative Immune Infiltration in Colon Adenocarcinoma
Xiukun Chai, Wei Qi, Chunyan Zou, et al.
Frontiers in Genetics (2021) Vol. 12
Open Access | Times Cited: 8
Xiukun Chai, Wei Qi, Chunyan Zou, et al.
Frontiers in Genetics (2021) Vol. 12
Open Access | Times Cited: 8
Analysis of the prognostic significance and potential mechanisms of lncRNAs associated with m6A methylation in papillary thyroid carcinoma
Yinde Huang, Xin Li, Wenbin Chen, et al.
International Immunopharmacology (2021) Vol. 101, pp. 108286-108286
Closed Access | Times Cited: 7
Yinde Huang, Xin Li, Wenbin Chen, et al.
International Immunopharmacology (2021) Vol. 101, pp. 108286-108286
Closed Access | Times Cited: 7
Computational epigenetic landscape analysis reveals association of CACNA1G-AS1, F11-AS1, NNT-AS1, and MSC-AS1 lncRNAs in prostate cancer progression through aberrant methylation
Mahafujul Islam Quadery Tonmoy, Atqiya Fariha, Ithmam Hami, et al.
Scientific Reports (2022) Vol. 12, Iss. 1
Open Access | Times Cited: 5
Mahafujul Islam Quadery Tonmoy, Atqiya Fariha, Ithmam Hami, et al.
Scientific Reports (2022) Vol. 12, Iss. 1
Open Access | Times Cited: 5